Watkins Sees Human Genome Growth on Benlysta for `Years'
488 views · Published 27 June 2011 · 4:15 · Indexed 4 November 2026
Channel: Bloomberg Originals · 2011 · Entertainment
June 27 (Bloomberg) -- Thomas Watkins, chief executive officer of Human Genome Sciences Inc., talks about Human Genome's Benlysta therapy for Lupus.
Watkins also discusses drug pricing. He speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington on Bloomberg Television's "Fast Forward." (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg